NEW YORK–(BUSINESS WIRE)–Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating potential claims against Trulieve Cannabis Corporation (Other OTC: TCNNF) on behalf of Trulieve stockholders. Our investigation concerns whether Trulieve has violated the federal securities laws and/or engaged in other unlawful business practices.
Click here to participate in the action.
On December 17, 2019, Grizzly Research published an article reporting that the majority of the Company’s cultivation space comes from “hoop houses that produce low quality output,” that there were extensive ties between Trulieve and ongoing FBI corruption investigations, that the Company’s initial license approval “stinks of corruption,” and that the Company engaged in various undisclosed related party transactions.
On this news, Trulieve’s stock price fell $1.51 per share, or over 12.6%, to close at $10.40 per share on December 17, 2019.
If you purchased or otherwise acquired Trulieve shares and suffered a loss, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at firstname.lastname@example.org, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.